Skip to search formSkip to main contentSkip to account menu

Emfilermin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

leukemia inhibitory factor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A Randomized, Double-blinded, Placebo-controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy
2004
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2003
2003
A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancer.
PURPOSE Leukemia inhibitory factor (LIF) is a pleiotropic molecule of the interleukin 6 family of cytokines. We aimed to examine… 
2003
2003
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)